BCDA — BioCardia Cashflow Statement
0.000.00%
Last trade - 00:00
- $9.67m
- $8.57m
- $0.48m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14.7 | -15 | -12.6 | -11.9 | -11.6 |
Depreciation | |||||
Non-Cash Items | 3.74 | 2.94 | 2.26 | 1.48 | 1.36 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.41 | -0.365 | -0.063 | -0.214 | 0.152 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -9.45 | -12.4 | -10.4 | -10.6 | -9.97 |
Capital Expenditures | -0.146 | -0.032 | -0.116 | -0.07 | -0.012 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.146 | -0.032 | -0.116 | -0.07 | -0.012 |
Financing Cash Flow Items | -1.26 | -2.79 | -0.059 | -0.418 | -0.662 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 9.82 | 28.2 | 1.95 | 5.12 | 3.73 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.227 | 15.8 | -8.54 | -5.51 | -6.26 |